Angiotensin II Receptor–Independent Antiinflammatory and Antiaggregatory Properties of Losartan
- 19 April 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 90 (7), 770-776
- https://doi.org/10.1161/01.res.0000014434.48463.35
Abstract
Angiotensin II (Ang II) type 1 receptor (AT1) antagonists such as losartan (LOS) are widely used for the treatment of hypertension and elicit antiinflammatory and antiaggregatory in vitro and in pa...Keywords
This publication has 18 references indexed in Scilit:
- Angiotensin II Subtype 1 Receptor Blockers and Renal FunctionArchives of Internal Medicine, 2001
- Atherosclerosis as an infectious, inflammatory and autoimmune diseaseTrends in Immunology, 2001
- Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: The LIFE StudyAmerican Heart Journal, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic LesionsThe American Journal of Pathology, 1999
- Angiotensin II attenuates renal cortical cyclooxygenase-2 expressionJournal of Clinical Investigation, 1999
- Regulation and metabolism of arachidonic acidClinical Reviews in Allergy & Immunology, 1999
- Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial designThe American Journal of Cardiology, 1999
- Specific and rapid quantification of 8-iso-prostaglandin F2α in urine of healthy humans and patients with Zellweger syndrome by gas chromatography–tandem mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997